Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

The entirely subcutaneous implantable cardioverter-defibrillator: initial clinical experience in a large Dutch cohort.

Olde Nordkamp LR, Dabiri Abkenari L, Boersma LV, Maass AH, de Groot JR, van Oostrom AJ, Theuns DA, Jordaens LJ, Wilde AA, Knops RE.

J Am Coll Cardiol. 2012 Nov 6;60(19):1933-9. doi: 10.1016/j.jacc.2012.06.053. Epub 2012 Oct 10.

2.

Outcome and complications after implantable cardioverter defibrillator therapy in hypertrophic cardiomyopathy: systematic review and meta-analysis.

Schinkel AF, Vriesendorp PA, Sijbrands EJ, Jordaens LJ, ten Cate FJ, Michels M.

Circ Heart Fail. 2012 Sep 1;5(5):552-9. Epub 2012 Jul 20. Review.

3.

Development of the subcutaneous implantable cardioverter-defibrillator for reducing sudden cardiac death.

Sanghera R, Sanders R, Husby M, Bentsen JG.

Ann N Y Acad Sci. 2014 Nov;1329:1-17. doi: 10.1111/nyas.12550. Epub 2014 Oct 10. Review.

PMID:
25308791
4.

Efficacy and safety of the subcutaneous implantable cardioverter defibrillator: a systematic review.

Chue CD, Kwok CS, Wong CW, Patwala A, Barker D, Zaidi A, Mamas MA, Cunnington C, Ahmed FZ.

Heart. 2017 Sep;103(17):1315-1322. doi: 10.1136/heartjnl-2016-310852. Epub 2017 Jul 7. Review.

PMID:
28687562
5.

Safety and Efficacy of the Subcutaneous Implantable Defibrillator.

Lewis GF, Gold MR.

J Am Coll Cardiol. 2016 Feb 2;67(4):445-454. doi: 10.1016/j.jacc.2015.11.026. Review.

6.

[Defibrillator implantation associated with ventricular arrhythmia ablation: an emerging hybrid approach].

Lavalle C, Pandozi C, Santini M.

G Ital Cardiol (Rome). 2012 Feb;13(2):110-7. doi: 10.1714/1021.11144. Review. Italian.

PMID:
22322551
7.

Development of an entirely subcutaneous implantable cardioverter-defibrillator.

Lupo PP, Pelissero G, Ali H, Sanghera R, Cappato R.

Prog Cardiovasc Dis. 2012 May-Jun;54(6):493-7. doi: 10.1016/j.pcad.2012.03.006. Review.

PMID:
22687590
8.

Impact of prolonged implantable cardioverter-defibrillator arrhythmia detection times on outcomes: a meta-analysis.

Scott PA, Silberbauer J, McDonagh TA, Murgatroyd FD.

Heart Rhythm. 2014 May;11(5):828-35. doi: 10.1016/j.hrthm.2014.02.009. Epub 2014 Feb 12. Review.

PMID:
24530622
9.

Advances in sudden death prevention: the emerging role of a fully subcutaneous defibrillator.

Majithia A, Estes NA 3rd, Weinstock J.

Am J Med. 2014 Mar;127(3):188-94. doi: 10.1016/j.amjmed.2013.10.018. Epub 2013 Nov 7. Review.

PMID:
24411409
10.

Adverse events following implantable cardioverter defibrillator implantation: a systematic review.

Persson R, Earley A, Garlitski AC, Balk EM, Uhlig K.

J Interv Card Electrophysiol. 2014 Aug;40(2):191-205. doi: 10.1007/s10840-014-9913-z. Epub 2014 Jun 20. Review.

PMID:
24948126
11.

The Subcutaneous Implantable Cardioverter Defibrillator.

Mangels D, Frishman WH.

Cardiol Rev. 2016 Sep-Oct;24(5):248-55. doi: 10.1097/CRD.0000000000000099. Review.

PMID:
26807549
12.

Recent advances in the entirely subcutaneous ICD System.

Bettin M, Reinke F, Rath B, Köbe J, Eckardt L.

F1000Prime Rep. 2015 Apr 2;7:46. doi: 10.12703/P7-46. eCollection 2015. Review.

13.

Subglandular placement of an implantable cardioverter-defibrillator for an improved cosmetic outcome.

Wright CD, Roehl KR, Stephen Huang SK, Mahabir RC.

Ann Plast Surg. 2013 Nov;71(5):621-3. doi: 10.1097/SAP.0b013e318250f06c. Review.

PMID:
23429217
14.

Subcutaneous implantable cardioverter defibrillators in children, young adults and patients with congenital heart disease.

Bordachar P, Marquié C, Pospiech T, Pasquié JL, Jalal Z, Haissaguerre M, Thambo JB.

Int J Cardiol. 2016 Jan 15;203:251-8. doi: 10.1016/j.ijcard.2015.09.083. Epub 2015 Sep 26. Review.

PMID:
26519678
15.

Implantable cardioverter-defibrillators in adults with congenital heart disease: a systematic review and meta-analysis.

Vehmeijer JT, Brouwer TF, Limpens J, Knops RE, Bouma BJ, Mulder BJ, de Groot JR.

Eur Heart J. 2016 May 7;37(18):1439-48. doi: 10.1093/eurheartj/ehv735. Epub 2016 Feb 11. Review.

16.

The subcutaneous ICD-current evidence and challenges.

Patel KH, Lambiase PD.

Cardiovasc Diagn Ther. 2014 Dec;4(6):449-59. doi: 10.3978/j.issn.2223-3652.2014.12.02. Review.

17.

ICD programming.

Biffi M.

Indian Heart J. 2014 Jan-Feb;66 Suppl 1:S88-100. doi: 10.1016/j.ihj.2013.11.007. Epub 2013 Dec 20. Review.

18.

The entirely subcutaneous defibrillator (s-icd): state of the art and selection of the ideal candidate.

De Maria E, Olaru A, Cappelli S.

Curr Cardiol Rev. 2015;11(2):180-6. Review.

Supplemental Content

Support Center